For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250613:nRSM8375Ma&default-theme=true
RNS Number : 8375M Bellevue Healthcare Trust PLC 13 June 2025
Result of General Meeting
Bellevue Healthcare Trust plc (the "Company") is pleased to announce that the
special resolution put forward at its General Meeting held earlier today was
passed, authorising the Company to make purchases of its own shares, in order
to support the continued operation of the Zero Discount Policy.
The text of the resolution is continued in the shareholder circular (the
"Circular"), which is available on the Company's website at
www.bellevuehealthcaretrust.com (http://www.bellevuehealthcaretrust.com)
The proxy votes received were as follows:
Special resolution In Favour / Discretionary Against Withheld
1.To give authority for the Company to purchase its own shares 46,811,542 93.66% 3,169,071 6.34% 15,543
At the time of the above meeting, the Company's issued ordinary share capital
consisted of 315,152,309 Ordinary Shares, of which 130,838,757 Ordinary shares
were held in Treasury. Therefore, the total number of voting rights in the
Company was 184,313,552. Each Ordinary Share held entitles the holder to one
vote and there are no restrictions on those voting rights. A "Vote withheld"
is not a vote in law and is not counted in the calculation of the % of shares
voted "For" or "Against" a resolution.
Copies of the resolution passed will be submitted to the National Storage
Mechanism and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)
13 June 2025
Enquiries
NSM Funds (UK) Limited
bellevue@nsm.group (mailto:bellevue@nsm.group)
Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ROMFLFFVRLIVLIE